Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia

Elena J. Orlando(Novartis (Switzerland)), Xia Han(Novartis (United States)), Catherine Tribouley(Novartis (United States)), Patricia A. Wood(Novartis (United States)), Rebecca Leary(Novartis (United States)), Markus Riester(Novartis (United States)), John E. Levine(Icahn School of Medicine at Mount Sinai), Muna Qayed(Emory University), Stephan A. Grupp(Children's Hospital of Philadelphia), Michael Boyer(University of Utah), Barbara De Moerloose(Ghent University Hospital), Eneida R. Nemecek(Oregon Health & Science University), Henrique Bittencourt(Centre Hospitalier Universitaire Sainte-Justine), Hidefumi Hiramatsu(Kyoto University), Jochen Buechner(Oslo University Hospital), Stella M. Davies(Cincinnati Children's Hospital Medical Center), Michael R. Verneris(University of Minnesota), Kevin T. Nguyen(Navidea Biopharmaceuticals (United States)), Jennifer L. Brogdon(Novartis (United States)), Hans Bitter(Novartis (United States)), Michael Morrissey(Novartis (United States)), Piotr Pierog(Novartis (United States)), Serafino Pantano(Novartis (Switzerland)), Jeffrey A. Engelman(Novartis (United States)), Wendy Winckler(Novartis (United States))
Nature Medicine
September 27, 2018
Cited by 559

Abstract


Related Papers

No related papers found

Powered by citation graph analysis